| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Mar 04, 2026 | Sale | $323.08 | 2,309 | 745,984 | 36,500 | Mar 06, 2026, 04:12 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Mar 02, 2026 | Sale | $327.65 | 1,598 | 523,584 | 38,157 | Mar 04, 2026, 07:30 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Feb 27, 2026 | Option/RSU Exercise | - | 1,666 | - | 33,435 | Mar 02, 2026, 04:09 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Feb 13, 2026 | Sale | $310.08 | 1,959 | 607,448 | 31,769 | Feb 17, 2026, 07:27 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Jan 12, 2026 | Sale | $362.87 | 1,510 | 547,927 | 31,199 | Jan 14, 2026, 04:22 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Oct 02, 2025 | Sale | $452.05 | 1,405 | 635,126 | 28,788 | Oct 03, 2025, 05:14 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Aug 29, 2025 | Sale | $448.37 | 3,474 | 1,557,649 | 29,271 | Sep 02, 2025, 04:10 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Aug 18, 2025 | Sale | $453.27 | 1,396 | 632,759 | 30,823 | Aug 19, 2025, 05:28 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Feb 27, 2025 | Option/RSU Exercise | - | 1,667 | - | 14,858 | Mar 03, 2025, 04:31 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Feb 28, 2025 | Sale | $241.68 | 513 | 123,983 | 14,830 | Mar 03, 2025, 04:31 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Nov 26, 2024 | Sale | $250.98 | 1,469 | 368,686 | 14,634 | Nov 27, 2024, 05:21 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Jun 25, 2024 | Sale | $231.00 | 1,605 | 370,747 | 13,206 | Jun 26, 2024, 04:26 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Feb 27, 2024 | Option/RSU Exercise | - | 1,667 | - | 5,737 | Feb 29, 2024, 04:18 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Feb 28, 2024 | Sale | $155.30 | 501 | 77,805 | 5,521 | Feb 29, 2024, 04:18 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Feb 16, 2024 | Sale | $148.06 | 1,009 | 149,397 | 4,710 | Feb 20, 2024, 04:08 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Apr 27, 2023 | Sale | $194.59 | 1,476 | 287,215 | 3,155 | Apr 28, 2023, 05:55 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Feb 03, 2023 | Sale | $232.14 | 3,424 | 794,854 | 3,296 | Feb 03, 2023, 05:45 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Feb 01, 2023 | Option/RSU Exercise | - | 5,025 | - | 5,025 | Feb 03, 2023, 05:45 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Feb 02, 2023 | Sale | $226.01 | 1,601 | 361,839 | 4,952 | Feb 03, 2023, 05:45 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Aug 03, 2022 | Sale | $210.00 | 1,754 | 368,340 | 3,629 | Aug 05, 2022, 04:15 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Aug 04, 2022 | Tax Payment (Shares) | $191.73 | 1,788 | 342,817 | 2,011 | Aug 05, 2022, 04:15 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Aug 05, 2022 | Sale | $218.16 | 1,841 | 401,630 | 1,692 | Aug 05, 2022, 04:15 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Jul 05, 2022 | Sale | $150.00 | 1,754 | 263,100 | 1,754 | Jul 07, 2022, 04:06 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Feb 01, 2022 | Option/RSU Exercise | - | 5,026 | - | 5,026 | Feb 03, 2022, 04:10 PM |
| ALNY | | ALNYLAM PHARMACEUTICALS, INC. | Tolga Tanguler | EVP, Chief Commercial Officer | Feb 02, 2022 | Tax Payment (Shares) | $144.67 | 1,518 | 219,609 | 3,508 | Feb 03, 2022, 04:10 PM |
